Last updated: May 18, 2023
Sponsor: Meir Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Autism
Asperger's Disorder
Treatment
Parent intervention
Clinical Study ID
NCT05879705
0119-20-COM
Ages 30-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Phase A:
- Parents (father, mother or both) of an adolescent (male or female) aged 12- 18, who isa student in junior or high school.
- Medical diagnosis (by a neurologist or psychiatrist) of a HFASD (Level 1) according tothe criteria of DSM-5 or DSM-IV.
- Parents report regarding unmet functional needs / difficulties.
- Signed consent of at least one parent to attend all sessions for a period ofapproximately 13 weeks. Phase B:
• Receiving a score that defines disability in at least one of the following areas: sensoryprocessing / executive function / social-communication skills.
Exclusion
Exclusion Criteria:
- Unbalanced neurologic or psychiatric comorbidity with HFASD, having a major effect onfunctioning, based on parental report.
- Parents who are unable or unavailable (emotionally or for any other reason) toparticipate in the intervention or the implementation (based on self-report).
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Parent intervention
Phase:
Study Start date:
March 03, 2021
Estimated Completion Date:
September 30, 2023
Study Description
Connect with a study center
The Hebrew University of Jerusalem
Jerusalem,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.